A Prospective Study of the Safety of Lower Gastrointestinal Endoscopy During Pregnancy in Patients with Inflammatory Bowel Disease

被引:28
|
作者
de Lima, A. [1 ]
Zelinkova, Z. [1 ,2 ]
van der Woude, C. J. [1 ]
机构
[1] Erasmus MC, Rotterdam, Netherlands
[2] IBD Ctr, Bratislava, Slovakia
来源
JOURNAL OF CROHNS & COLITIS | 2015年 / 9卷 / 07期
关键词
Endoscopy; inflammatory bowel disease; pregnancy; BIRTH OUTCOMES; CROHNS-DISEASE; FOLLOW-UP; EFFICACY; WOMEN; RISK; COLONOSCOPY; WEIGHT;
D O I
10.1093/ecco-jcc/jjv079
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Introduction: Women with inflammatory bowel disease [IBD] have a higher risk of undergoing gastrointestinal [GI] endoscopy during pregnancy than healthy women. Data on endoscopic procedures during pregnancy in IBD women are limited. The aim of this study was to investigate the safety of lower GI endoscopy during pregnancy in IBD women. Methods: All consecutive IBD women who underwent endoscopy during pregnancy [cases] from 2008-2014 were prospectively included. Cases were matched 1: 1 on age, IBD medication, and disease activity with pregnant IBD patients without endoscopy during pregnancy [controls]. Maternal and neonatal outcomes were compared between the cases and controls. Adverse events [AEs] were assessed for a temporal relation and for an aetiological relation with the endoscopy. Results: In total, 42 pregnant IBD patients [19 Crohn's disease, 23 ulcerative colitis] underwent 47 lower GI endoscopies [12 colonoscopies/35 sigmoidoscopies]. Median maternal age was 30 years [interquartile range: 28-32]. Two spontaneous abortions were temporally and probably related to endoscopy; however, spontaneous abortion did not occur more often in cases than in controls (2 [4.8%] vs 10 [23.8%], p 0.01). Median birthweight was significantly lower in the cases compared with controls [3 017 g vs 3 495 g, p 0.01]. There were no significant differences in terms of gestational age at birth, congenital abnormalities, or APGAR scores. Conclusion: Although lower GI endoscopy in pregnant IBD women should only be performed when strongly indicated, we report no increased adverse outcomes for the mother or the newborn related to endoscopy in any of the three trimesters of pregnancy compared with controls.
引用
收藏
页码:519 / 524
页数:6
相关论文
共 50 条
  • [1] Is safety infliximb during pregnancy in patients with inflammatory bowel disease?
    Arguelles Arias, Federico
    Castro Laria, Luisa
    Barreiro-de Acosta, Manuel
    Garcia Sanchez, M. Valle
    Guerrero Jimenez, Pedro
    Gomez Garcia, M. Rosa
    Cordero Ruiz, Patricia
    Iglesias Flores, Eva
    Gomez Camacho, Federico
    Munoz, Enrique J. Dominguez
    Herrerias Gutierrez, Juan Manuel
    [J]. REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2012, 104 (02) : 59 - 64
  • [2] Ustekinumab during pregnancy in patients with inflammatory bowel disease: a prospective multicenter cohort study
    Biron, I. Avni
    Mishael, T.
    Zittan, E.
    Livne, M.
    Zinger, A.
    Tzadok, R.
    Goldenberg, R.
    Kopylov, U.
    Ron, Y.
    Hadar, E.
    Helman, S.
    Ollech, J.
    Farkash, R.
    Pauker, M.
    Yanai, H.
    Dotan, I.
    Shitrit, A. Bar-Gil
    [J]. JOURNAL OF CROHNS & COLITIS, 2022, 16 : I522 - I523
  • [3] Ustekinumab during pregnancy in patients with inflammatory bowel disease: a prospective multicentre cohort study
    Avni-Biron, Irit
    Mishael, Tali
    Zittan, Eran
    Livne-Margolin, Moran
    Zinger, Adar
    Tzadok, Roi
    Goldenberg, Rosie
    Kopylov, Uri
    Ron, Yulia
    Hadar, Eran
    Helman, Sarit
    Granovsky, Sorina Grisaru
    Ollech, Jacob E.
    Arazi, Ayelet
    Farkash, Rivka
    Pauker, Maor H.
    Yanai, Henit
    Dotan, Iris
    Shitrit, Ariella Bar-Gil
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 56 (09) : 1361 - 1369
  • [4] Ustekinumab during pregnancy in patients with inflammatory bowel disease: a prospective multicenter cohort study
    Biron, I. Avni
    Mishael, T.
    Zittan, E.
    Livne, M.
    Zinger, A.
    Tzadok, R.
    Goldenberg, R.
    Kopylov, U.
    Ron, Y.
    Hadar, E.
    Helman, S.
    Ollech, J.
    Farkash, R.
    Pauker, M.
    Yanai, H.
    Dotan, I.
    Shitrit, A. Bar-Gil
    [J]. JOURNAL OF CROHNS & COLITIS, 2022, 16 : I522 - I523
  • [5] USTEKINUMAB DURING PREGNANCY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A PROSPECTIVE MULTICENTER COHORT STUDY
    Avni-Biron, Irit
    Mishael, Tali
    Zittan, Eran
    Livne, Moran
    Zinger, Adar
    Tzadok, Roie
    Goldenberg, Rosalind
    Kopylov, Uri
    Ron, Yulia
    Hadar, Eran
    Helman, Sarit
    Ollech, Jacob
    Rivka, Farkash
    Pauker, Maor H.
    Yanai, Henit A.
    Dotan, Iris
    Shitrit, Ariella Bar-Gil
    [J]. GASTROENTEROLOGY, 2022, 162 (07) : S633 - S633
  • [6] Safety of Tioguanine During Pregnancy in Inflammatory Bowel Disease
    van den Berg, Sophie A.
    de Boer, Marjon
    van der Meulen-de Jong, Andrea E.
    Jansen, Jeroen M.
    Hoentjen, Frank
    Russel, Maurice G. V. M.
    Mahmmod, Nofel
    van Bodegraven, Adriaan A.
    van der Woude, C. Janneke
    Mulder, Chris J. J.
    de Boer, Nanne K. H.
    [J]. JOURNAL OF CROHNS & COLITIS, 2016, 10 (02): : 159 - 165
  • [7] Safety of Endoscopy in Patients With Inflammatory Bowel Disease During the COVID-19 Pandemic
    Navaneethan, Udayakumar
    Lourdusamy, Dennisdhilak
    LehnerNoguera, Vanessa
    Shen, Bo
    [J]. INFLAMMATORY BOWEL DISEASES, 2020, 26 (10) : E118 - E119
  • [8] Prospective Assessment of the Adalimumab Discontinuation During Pregnancy in Inflammatory Bowel Disease Patients
    Zelinkova, Zuzana
    van der Ent, Cokkie
    Kuipers, Ernst J.
    van der Woude, Christien J.
    [J]. GASTROENTEROLOGY, 2012, 142 (05) : S385 - S386
  • [9] Epidemiologic Characteristics of Patients With Inflammatory Bowel Disease Undergoing Gastrointestinal Endoscopy
    Thukkani, Nundhini
    Williams, Luke
    Sonnenberg, Amnon
    [J]. GASTROINTESTINAL ENDOSCOPY, 2010, 71 (05) : AB192 - AB192
  • [10] The safety and efficacy of gastrointestinal endoscopy during pregnancy
    Cappell, MS
    [J]. GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 1998, 27 (01) : 37 - +